Technology | Artificial Intelligence | May 13, 2019

FDA Approves Zebra Medical Vision's HealthPNX AI Chest X-ray Triage Product

ER and ICU X-rays can now be automatically triaged as acute cases with pneumothorax

FDA Approves Zebra Medical Vision's HealthPNX AI Chest X-ray Triage Product

May 13, 2019 — Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthPNX, an artificial intelligence (AI) alert for pneumothorax (PNX) based on chest X-rays.

The latest FDA clearance, received in May 2019, focuses on an AI alert for "stat" (urgent) findings of pneumothorax, and demonstrates a promising potential to substantially reduce turnaround time and increase the radiologist's confidence in making this diagnosis. Chest X-rays are one of the world's most used imaging modalities.

Pneumothorax is a condition in which there is an accumulation of gas within the pleural space between the lung and the chest wall. Without prompt management, pneumothorax can lead to total lung collapse and other potentially fatal complications. This condition is most commonly diagnosed by a chest X-ray scan, though it is one of the hardest to interpret, and is known for high disagreement rates even between experienced radiologists. Misdiagnosis or late-diagnosis of Pneumothorax impacts around 74,000 Americans per year.1

The patent pending technology automatically detects findings suggestive of pneumothorax based on CXR or digital radiography (DR) scans, and alerts the medical team. In hospitals where Zebra-Med's "All in one" (AI1) solution is integrated into the radiologist's worklist, the scan is flagged so that the radiologist can address it in a timely manner. This first-of-its-kind FDA-cleared solution can save physicians more than 80 percent of the time taken to reach the acute condition, compared to the traditional First In First Out (FIFO) methodology, according to Zebra Medical.

The chest X-ray AI network was trained using millions of images to identify more than 40 common clinical findings. The results of the Textray study demonstrate high rates of agreement between the algorithm and human radiologist experts.2

"In a clinical validation study we performed, Zebra-Med's acute CXR pneumothorax and CT Brain bleed products demonstrated a promising potential to substantially reduce turnaround time and increase the radiologist's confidence in making these diagnoses," said Terence Matalon, M.D., chairman of imaging at Albert Einstein Medical Center. Zebra-Med's AI1 Triage Solution is the first of its kind for both computed tomography (CT) scans and X-rays, and currently addresses two acute conditions: intracranial hemorrhages (head CTs, FDA-pending), and pneumothorax (chest X-rays).

For more information: www.zebra-med.com

References

1. Bintcliffe O., Maskell N. Spontaneous pneumothorax. British Medical Journal, May 8, 2014. doi: https://doi.org/10.1136/bmj.g2928

2. Laserson J., Lantsman C.D., Cohen-Sfady M., et al. TextRay: Mining Clinical Reports to Gain a Broad Understanding of Chest X-rays. arXiv, June 6, 2018. 

 

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Advances in long-length digital radiography are creating opportunities for visualization during spinal surgery, as well as pre- and post-operatively. Image courtesy of Fujifilm Medical Systems

Feature | Digital Radiography (DR) | July 19, 2019 | By Greg Freiherr
Recent advances in...
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...